Q32 Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jodie Pope Morrison, with a market cap of $72.0M.
Common questions about Q32 Bio
Q32 Bio is scheduled to report earnings for Q1 2026 on May 7, 2026.
Q32 Bio has approximately 39 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.